Features of cytokine profile in patients with sarcoidosis

Lazareva Nm, O. Baranova, I. Kudryavtsev, N. A. Arsentieva, N. Liubimova, T. Ses’, M. Ilkovich, A. Totolian
{"title":"Features of cytokine profile in patients with sarcoidosis","authors":"Lazareva Nm, O. Baranova, I. Kudryavtsev, N. A. Arsentieva, N. Liubimova, T. Ses’, M. Ilkovich, A. Totolian","doi":"10.15789/1563-0625-foc-2064","DOIUrl":null,"url":null,"abstract":"Sarcoidosis is an inflammatory disease of unknown etiology with damage to the lungs and other organs characterized by development of necrosis-free epithelioid cell granulomas. Granulomatous inflammation characterized by the activation of different immune systems cells, in particular T lymphocytes, and the cytokines production. Our study was aimed at investigating the characteristics of the cytokine profile of blood plasma in patients with sarcoidosis. We studied peripheral blood plasma samples of patients with sarcoidosis (n = 52). The control blood samples were taken from healthy volunteers (n = 22). The level of 46 cytokines (pg/ml) was determined, as follows: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL- 6, IL-7, IL-9, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IFNα2, IFNγ, TNFα, TNFβ, IL- 1ra, IL-10, EGF, FGF-2, Flt3 Ligand, G-CSF, GM-CSF, PDGF-AA, PDGF-AB / BB, TGFα, VEGF-A, sCD40L, CCL2, CCL3, CCL4, CCL5, CCL7, CCL11, CCL17, CCL20, CCL22, CXCL1, CXCL8, CXCL9, CXCL10, CXCL11, CXCL13, CX3CL1. Significantly higher levels of interleukins and some proinflammatory cytokines were found in the patients with sarcoidosis, i.e., IL-3, 0.70 vs 0.20, p = 0.003; IL-4, 14.37 vs 3.15, p = 0.009; IL-5, 1.06 vs 0.89, p < 0.001; IL-12 (p70), 1.27 vs 0.56, p = 0.028; IL-17A, 1.48 vs 0.43, p < 0.001; IFNα2, 41.79 vs 25.04, p = 0.003; IFNγ, 4.13 vs 1.14, p < 0.001; TNFα, 21.67 vs 6.70, p < 0.001; anti-inflammatory cytokine IL-10, 1.03 vs 0.45, p = 0.019; growth factors: FGF-2, 40.08 vs 30.58, p = 0.008, G-CSF, 24.18 vs 8.21, p = 0.006, and VEGF-A, 42.52 vs 26.76, p = 0.048; chemokines: CCL3, 3.86 vs 1.33, p < 0,001; CCL17, 78.24 vs 26.24, p < 0.001; CCL20, 7.19 vs 5.64, p = 0.021; CCL22, 660.60 vs 405.00, p < 0,001; CXCL9, 4013 vs 1142, p < 0,001; CXCL10, 565.90 vs 196.60, p < 0.001; CXCL11, 230.20 vs 121.10, p = 0.018; CX3CL1, 56.99 vs 5.16, p < 0.001. Peripheral blood chemokine CCL11 levels were significantly lower in patients compared to the group of healthy volunteers: 77.58 vs 124.70, p = 0.022. The features of the cytokine profile in patients with sarcoidosis may indicate their important role in the processes of formation and outcomes of granulomas. These issues require an additional detailed study, comparison with phenotypes, differential course and outcomes of the disease.","PeriodicalId":85139,"journal":{"name":"Medical immunology (London, England)","volume":"22 1","pages":"993-1002"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical immunology (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15789/1563-0625-foc-2064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Sarcoidosis is an inflammatory disease of unknown etiology with damage to the lungs and other organs characterized by development of necrosis-free epithelioid cell granulomas. Granulomatous inflammation characterized by the activation of different immune systems cells, in particular T lymphocytes, and the cytokines production. Our study was aimed at investigating the characteristics of the cytokine profile of blood plasma in patients with sarcoidosis. We studied peripheral blood plasma samples of patients with sarcoidosis (n = 52). The control blood samples were taken from healthy volunteers (n = 22). The level of 46 cytokines (pg/ml) was determined, as follows: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL- 6, IL-7, IL-9, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IFNα2, IFNγ, TNFα, TNFβ, IL- 1ra, IL-10, EGF, FGF-2, Flt3 Ligand, G-CSF, GM-CSF, PDGF-AA, PDGF-AB / BB, TGFα, VEGF-A, sCD40L, CCL2, CCL3, CCL4, CCL5, CCL7, CCL11, CCL17, CCL20, CCL22, CXCL1, CXCL8, CXCL9, CXCL10, CXCL11, CXCL13, CX3CL1. Significantly higher levels of interleukins and some proinflammatory cytokines were found in the patients with sarcoidosis, i.e., IL-3, 0.70 vs 0.20, p = 0.003; IL-4, 14.37 vs 3.15, p = 0.009; IL-5, 1.06 vs 0.89, p < 0.001; IL-12 (p70), 1.27 vs 0.56, p = 0.028; IL-17A, 1.48 vs 0.43, p < 0.001; IFNα2, 41.79 vs 25.04, p = 0.003; IFNγ, 4.13 vs 1.14, p < 0.001; TNFα, 21.67 vs 6.70, p < 0.001; anti-inflammatory cytokine IL-10, 1.03 vs 0.45, p = 0.019; growth factors: FGF-2, 40.08 vs 30.58, p = 0.008, G-CSF, 24.18 vs 8.21, p = 0.006, and VEGF-A, 42.52 vs 26.76, p = 0.048; chemokines: CCL3, 3.86 vs 1.33, p < 0,001; CCL17, 78.24 vs 26.24, p < 0.001; CCL20, 7.19 vs 5.64, p = 0.021; CCL22, 660.60 vs 405.00, p < 0,001; CXCL9, 4013 vs 1142, p < 0,001; CXCL10, 565.90 vs 196.60, p < 0.001; CXCL11, 230.20 vs 121.10, p = 0.018; CX3CL1, 56.99 vs 5.16, p < 0.001. Peripheral blood chemokine CCL11 levels were significantly lower in patients compared to the group of healthy volunteers: 77.58 vs 124.70, p = 0.022. The features of the cytokine profile in patients with sarcoidosis may indicate their important role in the processes of formation and outcomes of granulomas. These issues require an additional detailed study, comparison with phenotypes, differential course and outcomes of the disease.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结节病患者的细胞因子谱特征
结节病是一种病因不明的炎症性疾病,对肺部和其他器官造成损害,其特征是形成无坏死的上皮样细胞肉芽肿。以激活不同免疫系统细胞,特别是T淋巴细胞和产生细胞因子为特征的肉芽肿性炎症。我们的研究旨在研究结节病患者血浆中细胞因子谱的特征。我们研究了结节病患者(n=52)的外周血血浆样本。对照血样取自健康志愿者(n=22)。测定46种细胞因子的水平(pg/ml),如下:IL-1α、IL-1β、IL-2、IL-3、IL-4、IL-5、IL-6、IL-7、IL-9、IL-12(p40)、IL-12、p70、IL-13、IL-15、IL-17A、IFNα2、IFNγ、TNFα、TNFβ、IL-11a、IL-10、EGF、FGF-2、Flt3配体、G-CSF、GM-CSF、PDGF-AA、PDGF-AB/BB、TGFα、VEGF-A、sCD40L、CCL2、CCL3、CCL4、CCL5、CCL7。CCL11、CCL17、CCL20、CCL22、CXCL1、CXCL8、CXCL9、CXCL10、CXCL11,CXCL13、CX3CL1。结节病患者的白细胞介素和一些促炎细胞因子水平显著较高,即IL-3,0.70比0.20,p=0.003;IL-4,14.37 vs 3.15,p=0.009;IL-5,1.06 vs 0.89,p<0.001;IL-12(p70),1.27 vs 0.56,p=0.028;IL-17A,1.48 vs 0.43,p<0.001;IFNα2,41.79 vs 25.04,p=0.003;IFNγ,4.13 vs 1.14,p<0.001;TNFα,21.67 vs 6.70,p<0.001;抗炎细胞因子IL-10,1.03 vs 0.45,p=0.019;生长因子:FGF-2,40.08 vs 30.58,p=0.008;G-CSF,24.18 vs 8.21,p=0.006;VEGF-A,42.52 vs 26.76,p=0.048;趋化因子:CCL3,3.86 vs 1.33,p<0001;CCL17,78.24 vs 26.24,p<0.001;CCL20,7.19对5.64,p=0.021;CCL22660.60对405.00,p<0001;CXCL9,4013对1142,p<0001;CXCL10,565.90 vs 196.60,p<0.001;CXCL11230.20对121.10,p=0.018;CX3CL1,56.99 vs 5.16,p<0.001。与健康志愿者组相比,患者的外周血趋化因子CCL11水平显著降低:77.58比124.70,p=0.022。结节病患者细胞因子谱的特征可能表明它们在肉芽肿的形成过程和结果中的重要作用。这些问题需要额外的详细研究,与表型、不同病程和疾病结果进行比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Обоснование эффективности применения медикопсихологической реабилитации и цифровой психофизиологической терапии в регуляции формирования атеросклеротического процесса на уровне нейропептидно-цитокиновыхзвеньев иммунной системы при полиморбидной сердечно-сосудистой патологии, протекающей на фоне расс HLA diversity in the Russian population assessed by next generation sequencing Basophil activation: theoretical aspects and use in the diagnosis of allergic diseases Complex estimation of mitochondrial changes of immunocompetent blood cells in pregnant women with urgent and premature birth Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1